Preparation and application of 1-[(1H-indazol-7-yl)methyl]-3-arylthiourea derivatives
CN117800916BActive Publication Date: 2025-02-11SHENYANG PHARMA UNIV
Patent Information
- Application Number
- CN202311788884.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-22
- Publication Date
- 2025-02-11
- Estimated Expiration
- 2043-12-22
Smart Images
Figure CN117800916B_ABST
Abstract
The present invention discloses the preparation and application of 1-[(1H-indazol-7-yl)methyl]-3-arylthiourea derivatives, belonging to the field of medical technology. Specifically, the 1-[(1H-indazol-7-yl)methyl]-3-arylthiourea derivatives or pharmaceutically acceptable salts thereof are shown in formula I, wherein R is as described in the specification. The 1-[(1H-indazol-7-yl)methyl]-3-arylthiourea derivatives and the pharmaceutically acceptable salts of the compounds can be combined with existing drugs or used alone as influenza virus inhibitors, and have good therapeutic effects on various influenza.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Railway-crossing.
US1250126A
HIV-1 protease urea inhibitor
CN103159686A
N-indazole substituted thiourea derivatives and preparation method and application thereof
CN105753841A